openPR Logo
Press release

Next Generation Genomics Market: Current trends, Opportunities, Challenges and Forecast by 2025

04-28-2017 09:08 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Global Next Generation Genomics Market, Next Generation Genomics Market Industry

Global Next Generation Genomics Market, Next Generation Genomics Market Industry

The chromosome haploid sets arranged in microorganism or gamete manner are termed genomes. Genomics is the study of evolution, function, and structure of a variety of scales from an individual cell of the tumor. The genomics has been revolutionized by the introduction of next generation sequencing. DNA sequencing technology has viewed greater advancement with next generation genomics.

Next generation sequencing helps sequence the complete human genome in a very short span of time. Next generation genomics is expected to help in the diagnosis and risk analysis of the human body, more quickly and with higher efficacy. There are various tools available to understand, integrate, and organize large volumes of genome data that is used to analyze pipelines and workflows.

With growing technology the recent decade has witnessed a deluge in the practices of interrogating the cell proportions. With rapid growth in biotechnology and the healthcare technologies, next generation genomics is gaining awareness among the masses. With the increased need for the advanced treatment of illnesses such as cancer and tumors to name a few, there is a rapid emergence of healthcare technology.

Obtain Report Details @
http://www.transparencymarketresearch.com/next-generation-genomics-market.html

The primary market driver for next generation genomics is increased demand for the treatment of chronic diseases. Also, the next generation genomics market is driven by the declining costs of genes sequencing. Next generation genomics enables effective detection of such diseases with highest degree of accuracy. The world of medical diagnosis is expanding with the invention of newer technologies. Next generation genomics is one such factor that is leading to the growth of the medical industry. Unlike the days before the introduction of next generation genome, when sequencing consumed millions of dollars and years for researchers to produce a single human genome, next generation genomics is capable of sequencing the human genome in a single day at drastically lower costs.

The needs of medical science have changed and thus support the adoption of next generation genomics in the coming days. Major companies in the genome industry are investing in innovations and inventions that will give them an opportunity to develop more efficient genomics techniques. Next generation genomics is also moving toward agriculture and the environment. In agriculture the genome research aims to modify crops to resist diseases and pests. To study the complex ecosystems of animals and the plant species at the genetic level genomics is gaining attention in environmental study.

The next generation genomics market suffers from lack of awareness and the availability of genomics experts and well-trained genomics personnel, which may limit its growth. With such limitations, the adoption of next generation genomics technology is low. As the concept of next generation genomics is still nascent the growth of this market is expected to increase slowly.

Fill the form to Gain Deeper Insights on this Market @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20390

Next generation genomics can be typically categorized on the bases of data type: epigenomic data, sequence variation data, transcriptomic data, and interactome data. The application of next generation genomics can be done in two different types: RNA sequencing and CHIP sequencing.

Some of the companies engaged in next generation genomics market are AC-Gen Reading Life S.L., Cofactor Genomics, DNA Link Inc., Eurofins MWG Operon, Otogenetics Corporation, Zymo Research, ACGT Inc., CD Genomics Inc., Laragen, Inc., Lifecode Technologies Pvt LTD., Longhorn Vaccines & Diagnostics LLC., Eureka Genomics, and Oxford Gene Technology.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next Generation Genomics Market: Current trends, Opportunities, Challenges and Forecast by 2025 here

News-ID: 519531 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Genomics

Spatial Genomics & Transcriptomics Market to Witness Huge Growth by Key Players: …
The Spatial Genomics & Transcriptomics market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Spatial Genomics & Transcriptomics report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. The Spatial Genomics & Transcriptomics research report also provides
Spatial Genomics and Transcriptomics Market to Witness Huge Growth by Key Player …
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Spatial Genomics and Transcriptomics market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report. This
Artificial Intelligence for Genomics and Personalised Medicine Market 2021-28|| …
An artificial neural network can reveal patterns in huge amounts of gene expression data, and discover groups of disease-related genes. Scientists hope that the new method can eventually be applied within precision medicine and individualized treatment. Similar to diagnosing a disease using a genomic basis, AI can help identify which genes have been affected by harmful mutations so that they can be targeted in gene therapy. DNA repair after editing is
Artificial Intelligence In Genomics Market have Huge Growth of CAGR 52% By 2021- …
The recent report on the Artificial Intelligence In Genomics market offers a thorough assessment of the business vertical as well as a comprehensive overview of the industry and its key segments. According to the report, the growing technological developments and research advancements are contributing to the market's expansion. The report provides extensive insight into key market elements such as drivers, restraints, challenges, strategic expansions, market size and share, growth prospects,
AI in Genomics Market Top Manufacturers 2030 Fabric Genomics Inc., Verge Genomic …
Allied Market Research published a latest report titled, “AI in Genomics Market : Global Opportunity Analysis and Industry Forecast 2020-2027’’. The market report features the factors and top market trends that fuel the growth of the market. Avail sample report with Industry Insights @ https://www.alliedmarketresearch.com/request-sample/11921 Frontrunners in the AI in Genomics Market: The report includes the frontrunners in the market including Fabric Genomics Inc., Verge Genomics, Freenome Holdings, Inc., MolecularMatch Inc. These market
What's Driving the Spatial Genomics Market Growth? 10x Genomics, S2 Genomics, Na …
This Spatial Genomics Market research document is structured with the most excellent and advanced tools of collecting, recording, estimating and analysing market data. A profound knowledge of industrial unanimity, market trends and incredible techniques give client's an upper hand in the ABC industry. Businesses can effectively use the data, statistics, research, and insights about the market included in this Spatial Genomics Market report to make decisions about business strategies and